Almost, 400,000 people in the United States are suffering from this autoimmune disease, in which the body’s immune system starts to destroy the body's myelin and axons, thinking that they are foreign tissue. Essentially, the immune system cannot distinguish between its own tissue and foreign tissue. It is unclear why this disease starts, and if it is due to a muted gene or a virus. Most patients have the relapsing-remitting symptoms (less severe), whereas some have the progressive form (more severe). There is no cure for this disease except that Gilenya can delay the progression. This drug regulates immune responses, lessens the frequency and severity of relapses, tricks the immune system thereby reducing its attacks on myelin, and shortens the duration of a multiple
Almost, 400,000 people in the United States are suffering from this autoimmune disease, in which the body’s immune system starts to destroy the body's myelin and axons, thinking that they are foreign tissue. Essentially, the immune system cannot distinguish between its own tissue and foreign tissue. It is unclear why this disease starts, and if it is due to a muted gene or a virus. Most patients have the relapsing-remitting symptoms (less severe), whereas some have the progressive form (more severe). There is no cure for this disease except that Gilenya can delay the progression. This drug regulates immune responses, lessens the frequency and severity of relapses, tricks the immune system thereby reducing its attacks on myelin, and shortens the duration of a multiple